IGC Pharma (IGC) Receivables - Net (2016 - 2025)
IGC Pharma (IGC) has disclosed Receivables - Net for 15 consecutive years, with $41000.0 as the latest value for Q3 2025.
- Quarterly Receivables - Net fell 6.82% to $41000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $41000.0 through Sep 2025, down 6.82% year-over-year, with the annual reading at $34000.0 for FY2025, 12.82% down from the prior year.
- Receivables - Net for Q3 2025 was $41000.0 at IGC Pharma, down from $87000.0 in the prior quarter.
- The five-year high for Receivables - Net was $251000.0 in Q4 2022, with the low at $28000.0 in Q2 2024.
- Average Receivables - Net over 5 years is $117578.9, with a median of $125000.0 recorded in 2022.
- The sharpest move saw Receivables - Net tumbled 87.56% in 2024, then surged 210.71% in 2025.
- Over 5 years, Receivables - Net stood at $164000.0 in 2021, then skyrocketed by 53.05% to $251000.0 in 2022, then plummeted by 63.35% to $92000.0 in 2023, then tumbled by 46.74% to $49000.0 in 2024, then fell by 16.33% to $41000.0 in 2025.
- According to Business Quant data, Receivables - Net over the past three periods came in at $41000.0, $87000.0, and $34000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.